Official Journal of the Italian Society of Orthopaedics and Traumatology
Table 2 Average data (a) before treatment in both groups (SD in brackets), (b) after treatment in both groups (SD in brackets)
From: Use of palmitoylethanolamide in carpal tunnel syndrome: a prospective randomized study
Group N | Group P | p value | |
|---|---|---|---|
(a) | |||
Positive Phalen’s test | 4 | 9 | 0.1344 (χ = 2.2406) |
Positive Durkan’s test | 17 | 18 | 0.9121 (χ = 0.0121) |
VAS | 4.26 (3.41) | 4.06 (3.42) | 0.8182 (t = 0.2309) |
FSS | 2.03 (0.75) | 2.24 (0.66) | 0.2469 (t = −1.1696) |
SSS | 2.59 (0.76) | 2.57 (0.74) | 0.9217 (t = 0.0988) |
Sensitive latency | 3.41 (0.99) | 3.32 (1.01) | 0.7328 (t = 0.343) |
Sensitive peak amplitude | 10.82 (10.39) | 8.86 (5.42) | 0.3671 (t = 0.9091) |
Sensitive speed | 40.15(8.08) | 40.53 (7.05) | 0.8479 (t = 0.1927) |
Motor latency | 4.01 (0.96) | 3.87 (0.91) | 0.5936 (t = 0.5372) |
Motor peak amplitude | 7.87 (3.7) | 7.98 (3.06) | 0.9148 (t = −0.1076) |
(b) | |||
Positive Phalen’s test | 9 | 13 | 0.3812 (χ = 0.7667) |
Positive Durkan’s test | 21 | 19 | 0.4741 (χ = 0.5123) |
VAS | 3.76 (3.19) | 3.25 (3.18) | 0.5356 (t = 0.6231) |
FSS | 1.80 (0.81) | 1.96 (0.77) | 0.4329 (t = −0.7896) |
SSS | 2.25 (0.86) | 2.11 (0.81) | 0.5078 (t = 0.6663) |
Sensitive latency | 3.33 (0.81) | 3.55 (1.6) | 0.5264 (t = −0.638) |
Sensitive peak amplitude | 10.93 (7.65) | 11.12 (6.13) | 0.9208 (t = −0.1) |
Sensitive speed | 38.39 (7.87) | 42.00 (8.54) | 0.128 (t = −1.5489) |
Motor latency | 3.82 (0.63) | 3.71 (0.7) | 0.5867 (t = 0.5478) |
Motor peak amplitude | 8.45 (2.74) | 8.23 (2.43) | 0.7922 (t = 0.2652) |